Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://www.targetedonc.com/view/novel-peptide-based-vaccine-demonstrates-safe-in-advanced-nsclc
0
0
Novel Peptide Based Vaccine Demonstrates Safe in Advanced NSCLC - Targeted Oncology
10/7/22 at 10:01am
Organization
Targetedonc.com
Author
Jordyn Sava
Details
47 words
Summarize
Cancer
Health
Novel Peptide Based Vaccine Demonstrates Safe
Oncology Findings
NSCLC
Findings from the phase 1b/2a trial evaluating a universal cancer peptide-based vaccine at a 3-dose schedule in patients with metastatic non–small cell lung cancer showed the vaccine to be safe and effective.
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...